Abstract
BackgroundSclerosing hemangioma (SH) of the lung is a kind of rare pulmonary tumor. Preoperative diagnosis of this tumor is difficult and it is now generally accepted that SH of the lung is benign lesions and surgical excision alone is curative. Herein, we present our experiences of treating 28 patients with SH.MethodsThe medical records of 28 patients with SH from 1994 to 2010 at the Department of Thoracic Surgery in Beijing Chest Hospital were retrospectively reviewed.ResultsThere were 3 male and 25 female patients with sclerosing hemangioma and 50% of the patients were asymptomatic. Preoperatively, all the patients had undergone CT of chest and 5 patients had undergone PET scan but 4 patients were misdiagnosed as malignancy. There was no operative mortality or tumor recurrence despite that three different operative methods were undertaken.ConclusionsSH has a high incidence in middle-aged women. Most of SH is asymptomatic and the symptoms of SH are not related to the tumor size and distribution. The features of chest CT and PET are not specific. Bilateral or multiple lesions should not exclude the possibility of SH. Complete excision of lesion is a curable treatment method and there is no evidence to verify the need of adjuvant therapy.
Highlights
Sclerosing hemangioma (SH) of the lung is a kind of rare pulmonary tumor
Among the symptomatic patients 7 presented with hemoptysis, 9 presented with cough, 3 presented with chest pain, 1 presented with expectoration sputum and 1 presented with fever
We analyzed the diameters of the tumors and the possibility of presenting symptoms using the Logistic regression (SPSS version 13.0), the P value was 1.000 and suggested that the symptoms were not related to the tumor size
Summary
Sclerosing hemangioma (SH) of the lung is a kind of rare pulmonary tumor. Preoperative diagnosis of this tumor is difficult and it is generally accepted that SH of the lung is benign lesions and surgical excision alone is curative. Sclerosing hemangioma (SH) of the lung is a kind of rare pulmonary tumor which was first reported in 1956 by Liebow and Hubbel [1]. Sclerosing hemangioma occurs in a wide age range (11-83 age)but is more common in middle-aged women [3,4] and has a higher incidence in Asia. It is generally accepted that sclerosing hemangioma of the lung is benign lesions and surgical excision alone is curative. This report describes our experience of surgery treatment of 28 patients with sclerosing hemangioma
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
